Identify which of Mesoblast Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.
|Drug Name||Generic Name||Brand Name||Company Name||Therapy Area||Indication||Development Stage||Drug Geography|
|MPC-75IA||-||RepliCart||Mesoblast Ltd||Musculoskeletal Disorders||Osteoarthritis||Phase II||Global|
|MPC-75IA||-||RepliCart||Mesoblast Ltd||Musculoskeletal Disorders||Cartilage Degeneration||Phase II||Global|
|MPC-25IC||rexlemestrocel-L||-||Mesoblast Ltd||Cardiovascular||Myocardial Infarction||Phase II||Global|
Pipeline Drugs is one of the primary repositories of pharmaceutical drug information offered by GlobalData.
This contains focused and comprehensive coverage of pharmaceuticals in development, an exhaustive resource for the users.
The dataset allows users to quickly identify specific information of value for actionable insights.
Pipeline Drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval.
Marketed Drugs seeking approval for additional indications or in additional markets are included.
Keep up-to-date on new Pipeline drug developments.
Competitive analysis of Pipeline drugs.
Pipeline Drugs is equipped to facilitate both qualitative and quantitative analysis.
Profiles offer detailed pharmacological and Research and Development (R&D) information affording users the market insight necessary for accurate decision making.
Expansive offering allow users to identify drugs by a wide range of characteristics and features ranging from a geography, company to a specific drug.
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer